<DOC>
	<DOCNO>NCT01160172</DOCNO>
	<brief_summary>The purpose study evaluate safety , reactogenicity immunogenicity several formulation investigational Staphylococcal vaccine .</brief_summary>
	<brief_title>A Study Evaluate Safety , Reactogenicity Immunogenicity GSK Biologicals ' Staphylococcal Investigational Vaccine Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol . A male female 18 40 year age , inclusive , time first vaccination . Written inform consent obtain subject . Healthy subject establish medical history , clinical examination laboratory assessment enter study . Female subject nonchildbearing potential may enrol study . Female subject childbearing potential may enrol study , subject : practiced adequate contraception 30 day prior vaccination , negative pregnancy test Screening , agree continue adequate contraception entire treatment period 2 month completion vaccination series Use investigational nonregistered product study vaccine within 30 day precede first dose study vaccine , plan use study period . Chronic administration immunosuppressant immunemodifying drug within 6 month prior first vaccine dose . Any clinically significant acute chronic , local systemic infection , proven suspect caused Staphylococcus aureus require antibiotic treatment , within 6 month precede first vaccination . Previous administration investigational Staphylococcus aureus vaccine/antibodies . History ; current bleeding coagulation disorder . Known suspected reaction hypersensitivity likely exacerbate component vaccine . History ; current autoimmune immunemediated disease . Administration plan administration , vaccine foreseen study protocol within 30 day first dose vaccine 1 month last vaccine dose . Administration immunoglobulins and/or blood product within last 3 month precede first dose study vaccine plan administration study period . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection . Any clinically relevant abnormal haematological biochemical urine laboratory value screen . Any acute chronic , clinically significant disease , determine physical examination laboratory screen test . Acute disease and/or fever study entry . Pregnant lactate female . Female plan become pregnant planning discontinue contraceptive precaution . History ; current alcoholism and/or drug abuse . Any condition principal investigator judge may interfere study finding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>vaccine</keyword>
	<keyword>young adult</keyword>
	<keyword>Staphylococcus aureus</keyword>
</DOC>